Recently learned from the Jiangsu Provincial Food and Drug Administration, this year, the pharmaceutical industry in Jiangsu Province has continued to maintain a steady high-speed growth momentum, the overall scale continues to expand, the quality and efficiency of economic operations continue to increase.
Up to now, there have been 423 pharmaceutical production enterprises, 378 wholesale and retail chain companies, 1,729 medical equipment manufacturers, 3,411 wholesale companies, and 16,130 retail pharmacies. In 2005, the province's pharmaceutical industry enterprises completed a total output value of 53.292 billion yuan, and this year is expected to increase further. Between January and October of the national pharmaceutical industry sales revenue and the top 100 profit companies, Jiangsu Province has 16 and 13 companies respectively. Finalists, number one in the country. Among the top 500 global companies, there are 12 multinational pharmaceutical companies, 6 of which are located in Jiangsu. Yangzijiang Pharmaceutical Group's total profits and total industrial output values ​​in 2004, 2005, and January-October of this year both ranked first among pharmaceutical companies in China, and ranked among the top 500 largest companies in China and the top 500 taxpayers in China.
In recent years, the Jiangsu Provincial Party Committee and the provincial government have attached great importance to the development of the pharmaceutical industry and have made the pharmaceutical industry one of the key industries for the development of the province. They have introduced a number of measures to support the rapid and healthy development of the pharmaceutical industry. Actively establish a platform for pharmaceutical science and technology innovation, encourage and support the development of innovative drugs, and strive to improve the company's ability to independently innovate. At present, Jiangsu Province has 200 pharmaceutical research institutes of various types, 21 drug clinical trial bases, and another drug safety evaluation center. Since 2005, a total of 45 new drugs have been reported, ranking among the top in the country. Supervise the implementation of GMP (Good Manufacturing Practice) and GSP (Pharmaceutical Business Quality Management Practice) as an opportunity to eliminate backwardness, integrate resources, and comprehensively improve the competitiveness of pharmaceutical companies. Up to now, there are 277 pharmaceutical production enterprises in Jiangsu Province that have passed GMP certification, and 351 pharmaceutical wholesale and retail chain enterprises have passed GSP certification. At the same time, it actively attracted multinational pharmaceutical companies to settle in Jiangsu. In 2006, among the newly-listed global Fortune 500 companies, pharmaceutical companies took 12 seats, among which 6 were Johnson & Johnson, GlaxoSmithKline, AstraZeneca, Roche, Wyeth, and Lilly, and Roche Pharmaceuticals was established in Switzerland. Jiangsu Original Drug R&D Center Co., Ltd. focuses on the research and development of innovative drugs. Up to now, Jiangsu Province has approved the establishment of 874 foreign-funded pharmaceutical and medical device manufacturing enterprises with a total investment of US$1.57 billion.
In addition, Jiangsu also strengthened its tracking services and created a pharmaceutical economics sector. We will fully support the construction of key pharmaceutical industry bases such as Taizhou Pharmaceutical Industrial Park, Lianyungang New Pharmaceutical Industrial Park, Suzhou Wuxi Export-oriented Pharmaceutical Industrial Park and Nanjing Pharmaceutical Valley. While implementing preferential policies such as priority acceptance and priority approval, tens of millions of yuan has been invested in the construction of the Taizhou Drug Testing Center to strengthen the drug inspection services for pharmaceutical companies in the park and to promote the development of the pharmaceutical industry in the entire park. Actively promote the rapid development of modern pharmaceutical logistics. Taizhou, Changzhou and other places have already started the construction of five pharmaceutical logistics centers, with a total investment of more than RMB 1.1 billion, and will form a distribution capacity of RMB 30 billion after being put into use. Taizhou Medical Hi-tech Industrial Park plans to build a national-level featured industrial park with obvious industrial features, complete supporting functions, active medical trade, and excellent investment environment through 5-10 years. At present, the park has implemented 30 contracted projects with a total investment of over 5 billion yuan. From the overall situation and development trend of the national economy in Jiangsu Province, the pharmaceutical industry has become one of the important economic growth points in Jiangsu Province.
Up to now, there have been 423 pharmaceutical production enterprises, 378 wholesale and retail chain companies, 1,729 medical equipment manufacturers, 3,411 wholesale companies, and 16,130 retail pharmacies. In 2005, the province's pharmaceutical industry enterprises completed a total output value of 53.292 billion yuan, and this year is expected to increase further. Between January and October of the national pharmaceutical industry sales revenue and the top 100 profit companies, Jiangsu Province has 16 and 13 companies respectively. Finalists, number one in the country. Among the top 500 global companies, there are 12 multinational pharmaceutical companies, 6 of which are located in Jiangsu. Yangzijiang Pharmaceutical Group's total profits and total industrial output values ​​in 2004, 2005, and January-October of this year both ranked first among pharmaceutical companies in China, and ranked among the top 500 largest companies in China and the top 500 taxpayers in China.
In recent years, the Jiangsu Provincial Party Committee and the provincial government have attached great importance to the development of the pharmaceutical industry and have made the pharmaceutical industry one of the key industries for the development of the province. They have introduced a number of measures to support the rapid and healthy development of the pharmaceutical industry. Actively establish a platform for pharmaceutical science and technology innovation, encourage and support the development of innovative drugs, and strive to improve the company's ability to independently innovate. At present, Jiangsu Province has 200 pharmaceutical research institutes of various types, 21 drug clinical trial bases, and another drug safety evaluation center. Since 2005, a total of 45 new drugs have been reported, ranking among the top in the country. Supervise the implementation of GMP (Good Manufacturing Practice) and GSP (Pharmaceutical Business Quality Management Practice) as an opportunity to eliminate backwardness, integrate resources, and comprehensively improve the competitiveness of pharmaceutical companies. Up to now, there are 277 pharmaceutical production enterprises in Jiangsu Province that have passed GMP certification, and 351 pharmaceutical wholesale and retail chain enterprises have passed GSP certification. At the same time, it actively attracted multinational pharmaceutical companies to settle in Jiangsu. In 2006, among the newly-listed global Fortune 500 companies, pharmaceutical companies took 12 seats, among which 6 were Johnson & Johnson, GlaxoSmithKline, AstraZeneca, Roche, Wyeth, and Lilly, and Roche Pharmaceuticals was established in Switzerland. Jiangsu Original Drug R&D Center Co., Ltd. focuses on the research and development of innovative drugs. Up to now, Jiangsu Province has approved the establishment of 874 foreign-funded pharmaceutical and medical device manufacturing enterprises with a total investment of US$1.57 billion.
In addition, Jiangsu also strengthened its tracking services and created a pharmaceutical economics sector. We will fully support the construction of key pharmaceutical industry bases such as Taizhou Pharmaceutical Industrial Park, Lianyungang New Pharmaceutical Industrial Park, Suzhou Wuxi Export-oriented Pharmaceutical Industrial Park and Nanjing Pharmaceutical Valley. While implementing preferential policies such as priority acceptance and priority approval, tens of millions of yuan has been invested in the construction of the Taizhou Drug Testing Center to strengthen the drug inspection services for pharmaceutical companies in the park and to promote the development of the pharmaceutical industry in the entire park. Actively promote the rapid development of modern pharmaceutical logistics. Taizhou, Changzhou and other places have already started the construction of five pharmaceutical logistics centers, with a total investment of more than RMB 1.1 billion, and will form a distribution capacity of RMB 30 billion after being put into use. Taizhou Medical Hi-tech Industrial Park plans to build a national-level featured industrial park with obvious industrial features, complete supporting functions, active medical trade, and excellent investment environment through 5-10 years. At present, the park has implemented 30 contracted projects with a total investment of over 5 billion yuan. From the overall situation and development trend of the national economy in Jiangsu Province, the pharmaceutical industry has become one of the important economic growth points in Jiangsu Province.
Vane Pump,Rotary Vane Pump,Sliding Vane Pump,Hydraulic Vane Pump
Dongguan Jinzhuang Hydraulic Technology Co., Ltd. , https://www.jinzhuanghydraulic.com